CD133-directed CAR T cells for advanced metastasis malignancies: A phase I trial.
Wang Y, Chen M, Wu Z, Tong C, Dai H, Guo Y, Liu Y, Huang J, Lv H, Luo C, Feng KC, Yang QM, Li XL, Han W.
Wang Y, et al. Among authors: luo c.
Oncoimmunology. 2018 May 7;7(7):e1440169. doi: 10.1080/2162402X.2018.1440169. eCollection 2018.
Oncoimmunology. 2018.
PMID: 29900044
Free PMC article.